Title: 2024 Hospital and Internal Medicine: A Clinical Review of Common Problems – Day 2 (Physician)

Faculty: Kendal Williams, M.D., M.P.H..; Lawrence H. Brent, M.D.

Release Date: 7/1/2024 Expiration Date: 7/1/2027

Day 2

Scleroderma and Raynaud’s Disease

Attendees of this presentation should be able to:

• Specify the clinical manifestations of scleroderma.
• Apply the ACR/EULAR classification criteria for systemic sclerosis.
• Utilize treatment available for the manifestations of scleroderma as per the current EULAR recommendations.
• Apply an appropriate diagnostic work-up and treatment of Raynaud’s phenomenon.

Idiopathic Inflammatory Myopathies

Attendees of this presentation should be able to:

• Diagnose idiopathic inflammatory myopathies and differentiate between inflammatory and other types of myopathies
• Evaluate patients with drug induced myopathies and other causes of elevated CPK
• Recommend treatment of idiopathic inflammatory myopathies and measure disease activity

Spondyloarthropathies

Attendees of this presentation should be able to:

• Distinguish the clinical features of the different spondyloarthropathies to improve diagnostic accuracy.
• Utilize clinical features, laboratory studies, and radiological studies to make a diagnosis of axial spondyloarthropathy.
• Prescribe pharmacologic agents according to ACR and EULAR recommendations and evidence-based results from clinical trials for patients with spondyloarthropathies.

Update on the Evaluation of Chest Pain

Attendees of this presentation will be able to:

• Based on recent standard of care publications, review the contribution of history, physical exam, and EKG findings to the evaluation of chest pain.
• Distinguish ischemic EKG changes from their common mimics.
• Apply the use of novel and standard cardiac biomarkers to the diagnosis of ACS.
• Based on the guidance from the ACC/AHAS and recent significant research studies, determine the best evaluation strategy for the individual chest pain patient.

Update on the Management of Acute Coronary Syndromes

Attendees of this presentation will be able to:

• Distinguish the forms of ACS and their relative prognoses.
• Based on the most recent AHA/ACC guidelines, apply the appropriate initial management of patients experiencing acute coronary syndromes.
• Based on the most recent AHA/ACC guidelines, categorize the therapeutic options for patients with unstable angina and post-MI.
• Based on the most recent AHA/ACC guidelines, employ the secondary prevention strategies for
• patients who have experienced an acute coronary syndrome.